Siriuspoint Ltd (SPNT) Stock Price & Analysis
Siriuspoint Ltd (SPNT) rose 1.51% to USD 22.18 as of June 10, 2026 at 00:46 UTC, according to Nexqual real-time market data.
SPNT last closed at USD 21.85; the session ranged USD 22.03–22.37 on volume of 404,886 shares. Market capitalization is $2.61B, with a 52-week range of USD 17.17–24.32 (NYQ). Source: Nexqual, June 10, 2026 at 00:46 UTC.
Key Statistics (as of June 10, 2026 at 00:46 UTC)
| Price | USD 22.18 |
|---|---|
| Change | ▲ 1.51% (up) |
| Previous Close | USD 21.85 |
| Open | USD 22.04 |
| Day Range | USD 22.03 – 22.37 |
| 52-Week Range | USD 17.17 – 24.32 |
| Volume | 404,886 shares |
| Market Cap | $2.61B |
| Exchange | NYQ |
Technical Analysis (SPNT)
Nexqual's technical model rates SPNT "SELL" based on 1 bullish and 4 bearish signals across 124 daily candles, as of June 10, 2026 at 00:46 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 47.88 (neutral) |
| vs SMA50 | Below (USD 22.72) |
| MACD | -0.39 (negative) |
Analyst Ratings (SPNT)
Wall Street analysts rate SPNT "Buy" based on 3 analysts, with a mean price target of USD 27 (range USD 23–31), per Nexqual as of June 10, 2026 at 00:46 UTC.
| Consensus Rating | Buy |
|---|---|
| Analyst Count | 3 |
| Mean Target | USD 27 |
| High Target | USD 31 |
| Low Target | USD 23 |
| Buy / Hold / Sell | 2 / 2 / 0 |
Earnings (SPNT)
| Next Earnings Date | 2026-08-04 |
|---|---|
| EPS Estimate | USD 0.65 |
| Revenue Estimate | $781.15M |
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2026-03-31 | USD 0.7 vs est 0.69 ▲ beat |
| 2025-12-31 | USD 0.7 vs est 0.57 ▲ beat |
| 2025-09-30 | USD 0.73 vs est 0.51 ▲ beat |
| 2025-06-30 | USD 0.66 vs est 0.57 ▲ beat |
Source: Nexqual, June 10, 2026 at 00:46 UTC.
Financials & Fundamentals (SPNT)
| Total Revenue | $3.03B |
|---|---|
| Revenue Growth (YoY) | +6.50% |
| Gross Margin | +24.77% |
| Operating Margin | +18.02% |
| Profit Margin | +16.51% |
| ROE | +23.11% |
| Debt / Equity | 30.52 |
| Current Ratio | 0.68 |
| Total Cash | $975.40M |
| Total Debt | $702.90M |
| Free Cash Flow | $467.22M |
Source: Nexqual, June 10, 2026 at 00:46 UTC.
Financial Health Score (SPNT)
Nexqual rates Siriuspoint Ltd's overall financial health "Solid" across five dimensions, as of June 10, 2026 at 00:46 UTC.
| Growth | Solid — Revenue +7% YoY (latest Q) |
|---|---|
| Profitability | Mixed — Gross margin 25%, operating 18% |
| Balance Sheet | Mixed — $975M cash vs $703M debt, net cash position |
| Cash Flow | Solid — FCF $467M, 15% margin |
| Efficiency | Strong — ROE 23%, ROA 2.4% |
Ownership (SPNT)
| Insider Ownership | +11.58% |
|---|---|
| Institutional Ownership | +87.25% |
| Shares Outstanding | 117.54M |
| Float | 103.01M |
| Short % of Float | +2.94% |
Source: Nexqual, June 10, 2026 at 00:46 UTC.
Leadership (SPNT)
Siriuspoint Ltd is led by Scott Egan ACMA (age 54), CEO & Director, per Nexqual as of June 10, 2026 at 00:46 UTC.
| CEO & Director | Scott Egan ACMA (age 54) |
|---|---|
| Group President & Chief Executive Officer of Global Reinsurance | David Evan Govrin (age 61) |
| CFO & Principal Accounting Officer | James John McKinney (age 45) |
| Chief Strategy & Corporate Development Officer | Philip Enan |
Major Backers & Investors (SPNT)
Notable institutional backers of Siriuspoint Ltd include Donald Smith & Co., Inc., American Century Companies Inc, SmallCap World Fund Inc, according to Nexqual as of June 10, 2026 at 00:46 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Donald Smith & Co., Inc. | 8.07% |
| American Century Companies Inc | 7.64% |
| SmallCap World Fund Inc | 4.83% |
| Capital Group | 4.76% |
| Victory Capital Management Inc. | 3.16% |
| Private Management Group, Inc. | 2.9% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| Vanguard Group | 18.01% |
| BlackRock | 15.76% |
| Dimensional Fund Advisors | 5.94% |
| State Street | 3.7% |
Source: Nexqual, June 10, 2026 at 00:46 UTC.
From Siriuspoint Ltd's Latest SEC 10-K Filing (filed 2026-02-24)
Key Strengths & Strategy (as disclosed to the SEC)
- Our approach to underwriting allows us to deploy our capital in a variety of lines of business and to capitalize on opportunities that we believe offer favorable returns on equity over the long term.
- Our approach is to be nimble and attuned to market opportunities within our segments of Insurance & Services and Reinsurance, allocating capital where we see profitable opportunity, while remaining disciplined and focused on our specified risk tolerances and areas of expertise.
- In London, we write on Lloyd's paper through our platform, Syndicate 1945, and in the U.S., we underwrite through SiriusPoint America.
- We believe we have developed strong business relationships with the management of many of our ceding companies and reinsurance intermediaries.
Partnerships
- Our global team performs claims oversight across our diverse underwriting portfolio and we work in partnership with our business line experts. 7 Our claims advocates support SiriusPoint's primary insurance business, in addition to handling oversight of claims associated with program administrators, MGAs, and TPAs.
- Investments We generally manage our investment portfolio to balance quality, liquidity, and diversification with asset/liability matching and investment return.
Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| JRVR | James River Group Holdings, Inc | USD 3.97 | ▲ 0.25% |
| EPAC | Enerpac Tool Group Corp. | USD 35.04 | ▲ 4.75% |
| STEP | StepStone Group Inc. | USD 43.04 | ▼ 4.16% |
| PIPR | Piper Sandler Companies | USD 79.12 | ▲ 3.2% |
| NBHC | National Bank Holdings Corporat | USD 42.68 | ▲ 1.16% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 10, 2026 at 00:46 UTC. This page is informational and not investment advice.